115 related articles for article (PubMed ID: 23070988)
1. Residue 75 of interleukin-8 is crucial for its interactions with glycosaminoglycans.
Nordsieck K; Pichert A; Samsonov SA; Thomas L; Berger C; Pisabarro MT; Huster D; Beck-Sickinger AG
Chembiochem; 2012 Nov; 13(17):2558-66. PubMed ID: 23070988
[TBL] [Abstract][Full Text] [Related]
2. Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach.
Möbius K; Nordsieck K; Pichert A; Samsonov SA; Thomas L; Schiller J; Kalkhof S; Teresa Pisabarro M; Beck-Sickinger AG; Huster D
Glycobiology; 2013 Nov; 23(11):1260-9. PubMed ID: 23982278
[TBL] [Abstract][Full Text] [Related]
3. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
Joseph PR; Mosier PD; Desai UR; Rajarathnam K
Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
[TBL] [Abstract][Full Text] [Related]
4. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
[TBL] [Abstract][Full Text] [Related]
5. The effect of interleukin-8 truncations on its interactions with glycosaminoglycans.
Nordsieck K; Baumann L; Hintze V; Pisabarro MT; Schnabelrauch M; Beck-Sickinger AG; Samsonov SA
Biopolymers; 2018 Aug; 109(10):e23103. PubMed ID: 29377072
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations of CXCL-8 and its interactions with a receptor peptide, heparin fragments, and sulfated linked cyclitols.
Gandhi NS; Mancera RL
J Chem Inf Model; 2011 Feb; 51(2):335-58. PubMed ID: 21299226
[TBL] [Abstract][Full Text] [Related]
7. NMR characterization of the binding properties and conformation of glycosaminoglycans interacting with interleukin-10.
Künze G; Gehrcke JP; Pisabarro MT; Huster D
Glycobiology; 2014 Nov; 24(11):1036-49. PubMed ID: 25002415
[TBL] [Abstract][Full Text] [Related]
8. Identification of a glycosaminoglycan binding surface on human interleukin-8.
Kuschert GS; Hoogewerf AJ; Proudfoot AE; Chung CW; Cooke RM; Hubbard RE; Wells TN; Sanderson PN
Biochemistry; 1998 Aug; 37(32):11193-201. PubMed ID: 9698365
[TBL] [Abstract][Full Text] [Related]
9. Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.
Skelton NJ; Quan C; Reilly D; Lowman H
Structure; 1999 Feb; 7(2):157-68. PubMed ID: 10368283
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a glycosaminoglycan binding site on interleukin-10 via molecular simulation methods.
Gehrcke JP; Pisabarro MT
J Mol Graph Model; 2015 Nov; 62():97-104. PubMed ID: 26409190
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic degradation of glycosaminoglycans.
Ernst S; Langer R; Cooney CL; Sasisekharan R
Crit Rev Biochem Mol Biol; 1995; 30(5):387-444. PubMed ID: 8575190
[TBL] [Abstract][Full Text] [Related]
12. Ligand binding of interleukin-8: a comparison of glycosaminoglycans and acidic peptides.
Schulze C; Danielsson A; Liwo A; Huster D; Samsonov SA; Penk A
Phys Chem Chem Phys; 2023 Sep; 25(36):24930-24947. PubMed ID: 37694394
[TBL] [Abstract][Full Text] [Related]
13. Docking glycosaminoglycans to proteins: analysis of solvent inclusion.
Samsonov SA; Teyra J; Pisabarro MT
J Comput Aided Mol Des; 2011 May; 25(5):477-89. PubMed ID: 21597992
[TBL] [Abstract][Full Text] [Related]
14. Flexibility and explicit solvent in molecular-dynamics-based docking of protein-glycosaminoglycan systems.
Samsonov SA; Gehrcke JP; Pisabarro MT
J Chem Inf Model; 2014 Feb; 54(2):582-92. PubMed ID: 24479827
[TBL] [Abstract][Full Text] [Related]
15. The structure of glycosaminoglycans and their interactions with proteins.
Gandhi NS; Mancera RL
Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
[TBL] [Abstract][Full Text] [Related]
16. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
17. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
Sepuru KM; Rajarathnam K
J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
[TBL] [Abstract][Full Text] [Related]
18. Development and application of site mapping methods for the design of glycosaminoglycans.
Agostino M; Gandhi NS; Mancera RL
Glycobiology; 2014 Sep; 24(9):840-51. PubMed ID: 24859723
[TBL] [Abstract][Full Text] [Related]
19. The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils.
Schlorke D; Thomas L; Samsonov SA; Huster D; Arnhold J; Pichert A
Carbohydr Res; 2012 Jul; 356():196-203. PubMed ID: 22444322
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR.
Montserret R; Aubert-Foucher E; McLeish MJ; Hill JM; Ficheux D; Jaquinod M; van der Rest M; Deléage G; Penin F
Biochemistry; 1999 May; 38(20):6479-88. PubMed ID: 10350466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
